EN
Embrotoxic and teratogenic effects of carbendazim were examined in Wistar rats for the product containing 98% a.i. of carbendazim and diaminophenazine contamination level of 1,1 ppm. The compound was administered by the oral route to pregnant rats during the organogenetic phase of gestation at doses: 0; 15, 30, 45 mg/kg b.w. and in the other group in diets at the concentration 2000 ppm. We found that carbendazim was teratogenic in rats if administered by the oral route but no incidence of fetuses malformations was observed when carbendazim was given in the diet.